Dentsply Sirona (XRAY): Assessing Valuation After Recent Share Price Decline

DENTSPLY SIRONA (XRAY) has been on investors’ radars recently following several months of challenging stock performance. The company’s share price is down 12% over the past 3 months, even as annual revenue creeps higher.

See our latest analysis for DENTSPLY SIRONA.

Despite some recent upticks, DENTSPLY SIRONA’s share price momentum continues to fade, with a 1-year total shareholder return of -44% and a 3-year total return of nearly -50%. While annual revenue has grown slightly, the stock’s continued slide suggests investors remain cautious as they weigh both the company’s turnaround potential and ongoing risks.

If this shift in sentiment has you thinking bigger, it is a good time to broaden your search and discover See the full list for free.

With shares now trading at a substantial discount to analyst targets and fundamentals showing mixed signals, the key question is whether DENTSPLY SIRONA remains undervalued or if the market has already accounted for any future turnaround.

Most Popular Narrative: 22.2% Undervalued

With a fair value estimate of $16.21 set against the last close price of $12.61, the narrative suggests the stock trades significantly below what analysts expect, stirring debate about the assumptions backing this potential upside.

Disciplined capital allocation toward innovation, organic growth, and financial flexibility, along with new leadership focused on execution, positions DENTSPLY SIRONA to capitalize on long-term industry consolidation and the shift toward value-based, high-quality dental care. This should support multi-year top-line and bottom-line growth.

Read the complete narrative.

Curious what ambitious profit and revenue turnaround is implied? The narrative leans on a striking rebound from losses and a valuation multiple not typical for the industry. Want the specifics? Only the full narrative reveals the projections behind this bold fair value target.

Result: Fair Value of $16.21 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, risks such as persistent sales declines and elevated costs could undermine DENTSPLY SIRONA’s turnaround narrative if these issues are not addressed effectively.

Find out about the key risks to this DENTSPLY SIRONA narrative.

Build Your Own DENTSPLY SIRONA Narrative

If you see the story differently or want to dig deeper into the data, you can craft your own take in just a few minutes. Do it your way.

A great starting point for your DENTSPLY SIRONA research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.

Looking for More Investment Ideas?

Get ahead of the curve and uncover investment opportunities that others might overlook. Make your next move confidently with these high-impact stock ideas curated for forward-thinking investors.

• Start earning while you invest and check out these 22 dividend stocks with yields > 3% with robust dividend yields above 3% for steady potential payouts.
• Tap into future tech leaders by tracking these 26 AI penny stocks making waves in artificial intelligence and powering the next boom in innovation.
• Build your watchlist with these 840 undervalued stocks based on cash flows showing compelling value based on strong cash flow metrics and attractive fundamentals.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com